Tracy and Jen VanHoutan were devastated when two of their children, Noah and Laine, were diagnosed with CLN2 Batten disease, a rare and fatal genetic disorder. The couple’s tireless quest for a cure paid off in April, when a drug was approved by the FDA, but only after Noah died.  (Alyssa Pointer/Chicago Tribune)

Tracy and Jen VanHoutan were devastated when two of their children, Noah and Laine, were diagnosed with CLN2 Batten disease, a rare and fatal genetic disorder. The couple’s tireless quest for a cure paid off in April, when a drug was approved by the FDA, but only after Noah died.  (Alyssa Pointer/Chicago Tribune)

Using Format